{
 "as_of": "2026-11-06",
 "cmr": "jp-cm-kg/TSE-GROWTH/4576",
 "fence": "The page is the record's research on the issuer — no analyst, no rating, no view.",
 "markdown": "The page is the record's research on the issuer — no analyst, no rating, no view.\n\n# D.Western Therapeutics Institute, Inc. (Growth Market: 4576) — research page\n\nAs of 2026-11-06 · jp-cm-kg · record version 1\n\n## Identity and listing\n\nThe issuer is D.Western Therapeutics Institute, Inc., listed on the Growth Market under ticker 4576. Its LEI is 529900V121NGDHXFA434. The ISIN is not on the record, as GLEIF maps no ISIN to this LEI. The security type is Corporate, the sector is 3250 Pharmaceutical, and the jurisdiction is Japan (EDINET domestic filer). The segment is not on the record. The issuer is listed and not halted.\n\n## The disclosure read\n\nThe record holds 9 filings in the twelve months to 2026-11-06, on 5 filing days. The filings comprise 2 ad hoc, 2 prospectus, 3 regulatory filing and 2 results. The median gap between filing days is 7.5 days. The latest filing is dated 2026-08-13, a regulatory filing, 85 days before the record date. The Growth Market median is 42 days cadence, 8.0 filings and 85.0 days latency across 598 issuers. The 3250 Pharmaceutical sector median is 49.5 days cadence, 8.0 filings and 85.0 days latency across 80 issuers.\n\n## Auditor\n\nThe auditor of record is 太陽有限責任監査法人. Its location is not on the record. The auditor changes are not on the record, as this register has no lifecycle type map.\n\n## Events and halts\n\nThe listing, delisting, name change, domicile change and segment move lines are not on the record, as this register has no lifecycle type map. The issuer is listed and not halted.\n\n## Orderability\n\nFor Qualified Institutional Investors the outcome is not determinable. The rule states a product scope, the subject's class carries no CFI to place on the scope bridge, and no scope object names the class, so the subject is not shown within the scope. The rule version is acm-68000/jp/suitability-principle-fiea-article-40/r1, with the chapter as of 2026-11-04.\n\n## Coverage\n\nNo research houses were found on the issuer's investor-relations pages read.\n\n## Open research\n\nThe record holds 2 openly published research notes, both by Sessa Investment Research, dated 2026-05-26 and 2020-04-22.\n\n## Licensed\n\nLicensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.\n\n## As-of depth\n\nNo sealed years hold the issuer, and the market's vintage is not sealed. The earliest sealed date of the market is not on the record, and the live record began is not on the record.\n\n## Sources\n\n10 source pages are named on this page; every value above carries its own source page and read date in the numbers.\n\n- https://www.jpx.co.jp/english/markets/statistics-equities/misc/tvdivq0000001vg2-att/data_e.xlsx (identity.exchange)\n- https://disclosure2dl.edinet-fsa.go.jp/searchdocument/codelist/Edinetcode.zip (identity.jurisdiction)\n- https://api.gleif.org/api/v1/lei-records/529900V121NGDHXFA434 (identity.lei)\n- https://mcp.jp-cm-kg.ai/events/TSE-GROWTH/4576 (the disclosure lines)\n- https://www.jpx.co.jp/markets/equities/suspended/index.html (the halt flag)\n- https://disclosure2.edinet-fsa.go.jp/WZEK0040.aspx?S100XS4G (the auditor)\n- https://mcp.jp-cm-kg.ai/book/aio.json (the orderability chapter)\n- https://pdf.irpocket.com/C4576/ccdN/I2DL/Exo8.pdf (open research)\n- https://pdf.irpocket.com/C4576/yCGV/Fnnr/DXyw.pdf (open research)\n- https://mcp.jp-cm-kg.ai/record/TSE-GROWTH/4576 (the record)\n",
 "market": "JP",
 "node": "jp-cm-kg",
 "numbers": {
  "as_of_depth": {
   "issuer_years_sealed": [],
   "live_record_began": null,
   "node_history_from": null,
   "node_years_sealed": [],
   "note": "the JP vintage is not sealed; the record is the live record as of 2026-11-06",
   "record_version": 1,
   "sealed": false
  },
  "auditor": {
   "auditor": {
    "read_by": "EDINET XBRL-to-CSV facts (API v2 type=5, 有価証券報告書 docTypeCode 120) — element jpcrp_cor:AuditFirm1Consolidated",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://disclosure2.edinet-fsa.go.jp/WZEK0040.aspx?S100XS4G",
    "state": "sourced",
    "value": "太陽有限責任監査法人"
   },
   "auditor_firm_id": {
    "market": "JP",
    "state": "not_on_record"
   },
   "auditor_location": {
    "market": "JP",
    "state": "not_on_record"
   },
   "changes": {
    "market": "JP",
    "reason": "no lifecycle type map for this register yet (SHELF-01: us and ca first)",
    "state": "not_on_record"
   }
  },
  "cmr": "jp-cm-kg/TSE-GROWTH/4576",
  "coverage": {
   "count": 0,
   "houses": [],
   "pages_checked": [],
   "read_by": "Perplexity sonar (search) · page read by this rail",
   "read_date": "2026-11-12",
   "since": null,
   "state": "none_found"
  },
  "disclosure": {
   "against": {
    "exchange": {
     "issuers": 598,
     "median_cadence_gap_days": 42,
     "median_filings": 8,
     "median_latency_days": 85,
     "name": "Growth Market"
    },
    "sector": {
     "issuers": 80,
     "median_cadence_gap_days": 49.5,
     "median_filings": 8,
     "median_latency_days": 85,
     "name": "3250 Pharmaceutical"
    }
   },
   "by_type": {
    "ad_hoc": 2,
    "prospectus": 2,
    "regulatory_filing": 3,
    "results": 2
   },
   "cadence_median_gap_days": 7.5,
   "filing_days": 5,
   "filings": 9,
   "latency_days": 85,
   "latest": [
    {
     "category": "135",
     "date": "2026-08-13",
     "source": "https://disclosure2.edinet-fsa.go.jp/WZEK0040.aspx?S100YVF1",
     "title": "確認書",
     "type": "regulatory_filing"
    },
    {
     "category": "半期報告書 (half-year report)",
     "date": "2026-08-13",
     "source": "https://disclosure2.edinet-fsa.go.jp/WZEK0040.aspx?S100YVEU",
     "title": "半期報告書－第29期(2026/01/01－2026/12/31)",
     "type": "results"
    },
    {
     "category": "臨時報告書 (extraordinary report)",
     "date": "2026-07-31",
     "source": "https://disclosure2.edinet-fsa.go.jp/WZEK0040.aspx?S100YTAX",
     "title": "臨時報告書",
     "type": "ad_hoc"
    },
    {
     "category": "040",
     "date": "2026-03-27",
     "source": "https://disclosure2.edinet-fsa.go.jp/WZEK0040.aspx?S100XV39",
     "title": "訂正有価証券届出書（組込方式）",
     "type": "prospectus"
    },
    {
     "category": "臨時報告書 (extraordinary report)",
     "date": "2026-03-27",
     "source": "https://disclosure2.edinet-fsa.go.jp/WZEK0040.aspx?S100XUJZ",
     "title": "臨時報告書",
     "type": "ad_hoc"
    }
   ],
   "latest_filing_date": "2026-08-13",
   "read": "the node's event lines (list_events_since), as get_filings serves them",
   "source": "https://mcp.jp-cm-kg.ai/events/TSE-GROWTH/4576",
   "window": {
    "from": "2025-11-06",
    "to": "2026-11-06"
   }
  },
  "identity": {
   "exchange": {
    "read_by": "JPX listed-issuers workbook (data_e.xlsx, English)",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://www.jpx.co.jp/english/markets/statistics-equities/misc/tvdivq0000001vg2-att/data_e.xlsx",
    "state": "sourced",
    "value": "Growth Market"
   },
   "isin": {
    "market": "JP",
    "reason": "GLEIF maps no ISIN to this LEI",
    "state": "not_on_record"
   },
   "jurisdiction": {
    "read_by": "EDINET code list (Edinetcode.zip, filer master with corporate number) (提出者種別)",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://disclosure2dl.edinet-fsa.go.jp/searchdocument/codelist/Edinetcode.zip",
    "state": "sourced",
    "value": "Japan (EDINET domestic filer)"
   },
   "lei": {
    "read_by": "GLEIF name-exact (English name against the legal or other names, jurisdiction JP; GLEIF golden copy 2026-09-12)",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://api.gleif.org/api/v1/lei-records/529900V121NGDHXFA434",
    "state": "sourced",
    "value": "529900V121NGDHXFA434"
   },
   "name": {
    "read_by": "JPX listed-issuers workbook (data_e.xlsx, English)",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://www.jpx.co.jp/english/markets/statistics-equities/misc/tvdivq0000001vg2-att/data_e.xlsx",
    "state": "sourced",
    "value": "D.Western Therapeutics Institute, Inc."
   },
   "sector": {
    "read_by": "JPX listed-issuers workbook (data_e.xlsx, English) (33-sector classification)",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://www.jpx.co.jp/english/markets/statistics-equities/misc/tvdivq0000001vg2-att/data_e.xlsx",
    "state": "sourced",
    "value": "3250 Pharmaceutical"
   },
   "security_type": {
    "read_by": "JPX listed-issuers workbook (data_e.xlsx, English)",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://www.jpx.co.jp/english/markets/statistics-equities/misc/tvdivq0000001vg2-att/data_e.xlsx",
    "state": "sourced",
    "value": "Corporate"
   },
   "segment": {
    "market": "JP",
    "state": "not_on_record"
   },
   "ticker": {
    "read_by": "JPX listed-issuers workbook (data_e.xlsx, English)",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://www.jpx.co.jp/english/markets/statistics-equities/misc/tvdivq0000001vg2-att/data_e.xlsx",
    "state": "sourced",
    "value": "4576"
   },
   "website": {
    "market": "JP",
    "state": "not_on_record"
   }
  },
  "licensed": {
   "columns": [
    "licensor",
    "entitlement",
    "title",
    "date",
    "source"
   ],
   "rows": [],
   "rule": "A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded."
  },
  "lifecycle": {
   "delisting": {
    "market": "JP",
    "reason": "no lifecycle type map for this register yet (SHELF-01: us and ca first)",
    "state": "not_on_record"
   },
   "domicile_change": {
    "market": "JP",
    "reason": "no lifecycle type map for this register yet (SHELF-01: us and ca first)",
    "state": "not_on_record"
   },
   "listing": {
    "market": "JP",
    "reason": "no lifecycle type map for this register yet (SHELF-01: us and ca first)",
    "state": "not_on_record"
   },
   "name_change": {
    "market": "JP",
    "reason": "no lifecycle type map for this register yet (SHELF-01: us and ca first)",
    "state": "not_on_record"
   },
   "segment_move": {
    "market": "JP",
    "reason": "no lifecycle type map for this register yet (SHELF-01: us and ca first)",
    "state": "not_on_record"
   }
  },
  "market": "JP",
  "node": "jp-cm-kg",
  "numbers_hash": "sha256:f1c99c707f3ff824c6ab45b9ec7878d79f965113934e442e43fb28c7f277f6c4",
  "open_research": {
   "read_date": "2026-11-12",
   "rows": [
    {
     "date": "2026-05-26",
     "kind": "issuer-sponsored",
     "publisher": "Sessa Investment Research",
     "read_by": "the note's link answers (200 application/pdf); a document, not read as text",
     "read_date": "2026-11-12",
     "source": "https://pdf.irpocket.com/C4576/ccdN/I2DL/Exo8.pdf",
     "state": "sourced",
     "title": "DWTI FY2026/12 Q1 Follow-up: Net sales down on lower royalty income, but pipeline progress warrants attention"
    },
    {
     "date": "2020-04-22",
     "kind": "issuer-sponsored",
     "publisher": "Sessa Investment Research",
     "read_by": "the note's link answers (200 application/pdf); a document, not read as text",
     "read_date": "2026-11-12",
     "source": "https://pdf.irpocket.com/C4576/yCGV/Fnnr/DXyw.pdf",
     "state": "sourced",
     "title": "D. Western Therapeutics Institute (DWTI)"
    }
   ],
   "state": "found"
  },
  "orderability": {
   "chapter_as_of": "2026-11-04",
   "client_categories": [
    "Qualified Institutional Investors"
   ],
   "outcomes": {
    "Qualified Institutional Investors": {
     "determinable": false,
     "reason": "the rule states a product scope; the subject's class carries no CFI to place on the scope bridge, and no scope object names the class: the subject is not shown within the scope",
     "signal": null
    }
   },
   "read": {
    "basis": "one live read per instrument class, halt state and client category on this market; this issuer's group",
    "chapter": "https://mcp.jp-cm-kg.ai/book/aio.json",
    "door": "https://mcp.jp-cm-kg.ai/mcp",
    "tool": "get_orderability"
   },
   "rule_version": "acm-68000/jp/suitability-principle-fiea-article-40/r1",
   "section": "jp.aio.v6"
  },
  "record": {
   "as_of": "2026-11-06",
   "url": "https://mcp.jp-cm-kg.ai/record/TSE-GROWTH/4576",
   "version": 1
  },
  "schema": "research-numbers v0.1 (USR-01, 2026-11-11)",
  "status": {
   "read_date": "2026-11-08",
   "source": "https://www.jpx.co.jp/markets/equities/suspended/index.html",
   "value": "listed, not halted"
  }
 },
 "numbers_hash": "sha256:f1c99c707f3ff824c6ab45b9ec7878d79f965113934e442e43fb28c7f277f6c4",
 "path": "/jp/TSE-GROWTH/4576",
 "schema": "research-page v0.1 (USR-02, 2026-11-11)",
 "sections": [
  {
   "id": "identity",
   "text": "The issuer is D.Western Therapeutics Institute, Inc., listed on the Growth Market under ticker 4576. Its LEI is 529900V121NGDHXFA434. The ISIN is not on the record, as GLEIF maps no ISIN to this LEI. The security type is Corporate, the sector is 3250 Pharmaceutical, and the jurisdiction is Japan (EDINET domestic filer). The segment is not on the record. The issuer is listed and not halted.",
   "title": "Identity and listing"
  },
  {
   "id": "disclosure",
   "text": "The record holds 9 filings in the twelve months to 2026-11-06, on 5 filing days. The filings comprise 2 ad hoc, 2 prospectus, 3 regulatory filing and 2 results. The median gap between filing days is 7.5 days. The latest filing is dated 2026-08-13, a regulatory filing, 85 days before the record date. The Growth Market median is 42 days cadence, 8.0 filings and 85.0 days latency across 598 issuers. The 3250 Pharmaceutical sector median is 49.5 days cadence, 8.0 filings and 85.0 days latency across 80 issuers.",
   "title": "The disclosure read"
  },
  {
   "id": "auditor",
   "text": "The auditor of record is 太陽有限責任監査法人. Its location is not on the record. The auditor changes are not on the record, as this register has no lifecycle type map.",
   "title": "Auditor"
  },
  {
   "id": "events",
   "text": "The listing, delisting, name change, domicile change and segment move lines are not on the record, as this register has no lifecycle type map. The issuer is listed and not halted.",
   "title": "Events and halts"
  },
  {
   "id": "orderability",
   "text": "For Qualified Institutional Investors the outcome is not determinable. The rule states a product scope, the subject's class carries no CFI to place on the scope bridge, and no scope object names the class, so the subject is not shown within the scope. The rule version is acm-68000/jp/suitability-principle-fiea-article-40/r1, with the chapter as of 2026-11-04.",
   "title": "Orderability"
  },
  {
   "id": "coverage",
   "text": "No research houses were found on the issuer's investor-relations pages read.",
   "title": "Coverage"
  },
  {
   "id": "open_research",
   "text": "The record holds 2 openly published research notes, both by Sessa Investment Research, dated 2026-05-26 and 2020-04-22.",
   "title": "Open research"
  },
  {
   "id": "licensed",
   "text": "Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.",
   "title": "Licensed"
  },
  {
   "id": "depth",
   "text": "No sealed years hold the issuer, and the market's vintage is not sealed. The earliest sealed date of the market is not on the record, and the live record began is not on the record.",
   "title": "As-of depth"
  },
  {
   "id": "sources",
   "text": "10 source pages are named on this page; every value above carries its own source page and read date in the numbers.",
   "title": "Sources"
  }
 ],
 "sources": [
  {
   "for": "identity.exchange",
   "source": "https://www.jpx.co.jp/english/markets/statistics-equities/misc/tvdivq0000001vg2-att/data_e.xlsx"
  },
  {
   "for": "identity.jurisdiction",
   "source": "https://disclosure2dl.edinet-fsa.go.jp/searchdocument/codelist/Edinetcode.zip"
  },
  {
   "for": "identity.lei",
   "source": "https://api.gleif.org/api/v1/lei-records/529900V121NGDHXFA434"
  },
  {
   "for": "the disclosure lines",
   "source": "https://mcp.jp-cm-kg.ai/events/TSE-GROWTH/4576"
  },
  {
   "for": "the halt flag",
   "source": "https://www.jpx.co.jp/markets/equities/suspended/index.html"
  },
  {
   "for": "the auditor",
   "source": "https://disclosure2.edinet-fsa.go.jp/WZEK0040.aspx?S100XS4G"
  },
  {
   "for": "the orderability chapter",
   "source": "https://mcp.jp-cm-kg.ai/book/aio.json"
  },
  {
   "for": "open research",
   "source": "https://pdf.irpocket.com/C4576/ccdN/I2DL/Exo8.pdf"
  },
  {
   "for": "open research",
   "source": "https://pdf.irpocket.com/C4576/yCGV/Fnnr/DXyw.pdf"
  },
  {
   "for": "the record",
   "source": "https://mcp.jp-cm-kg.ai/record/TSE-GROWTH/4576"
  }
 ],
 "title": "D.Western Therapeutics Institute, Inc. (4576) — research page",
 "writer": {
  "by": "Claude through the platform account, Haiku class; one pass; checked against the numbers",
  "engine": "claude-haiku-5-5"
 }
}